Omics analysis employs big data from high-throughput technologies including genetics information, profiles of transcription and protein, etc. to interpret the physiological and pathological characteristics of organisms. Our company provides a wide range of karyotype analysis methods and in-depth solutions to help you quickly grasp multi-omics information related to rare diseases.

Omics in Rare Disease Omics in rare diseases allows researchers to gain a comprehensive understanding into the pathogenesis of rare diseases from DNA, RNA and proteins that containing a huge amount of information by the application of various omics technologies, including genomics, epigenomics, transcriptomics, proteomics and metabonomics. The potential therapeutic targets are destined to be identified from the complex molecular networks and pathways. Services: Whole Genome Sequencing